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BY-NC-ND license (http://creativecomAbstract Background/purpose: The emergence of Klebsiella pneumoniae carbapenemase
(KPC)-producing strains is a challenge for clinicians. The characteristics and virulence of var-
iants of KPC-producing K. pneumoniae isolates were evaluated.
Methods: Five clinical isolatesdthree KPC subtypes from Taiwan (KPC2-TW, KPC3-TW, and
KPC17-TW) and two clinical strains from the United States (US; KPC2-US, KPC3-US)dwere
included. Virulent traits and capsular serotypes were analyzed by Polymerase Chain Reaction
(PCR). Serum killing, neutrophil phagocytosis, and mice lethargy studies were performed to
evaluate virulence.
Results: Multilocus sequence typing (MLST) demonstrated that KPC2-TW and KPC17-TW be-
longed to sequence type (ST)11, and KPC2-US, KPC3-US, and KPC3-TW to ST258. KPC3-TW ex-
pressed capsular serotype K1, whereas the others were non-K1/K2/K5 isolates. MLST analysis
indicated that ST11 strains were serum resistant, whereas ST258 isolates were serum sensitive.of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Number
aiwan.
edu.tw (J.-H. Chen).
.08.011
ociety of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC
mons.org/licenses/by-nc-nd/4.0/).
84 T.-T. Chiang et al.ST11 isolates exhibited significantly higher 15-minute phagocytic rates than ST258 isolates
(70.28  16.68% vs. 34.88 10.52%, p < 0.001). The capsular serotype K1 strain was more resis-
tant to neutrophil phagocytosis than non-K1/K2/K5 isolates (27.1  10.23% vs. 54.46  20.94%,
p Z 0.050). All KPC-producing strain variants from Taiwan and the US demonstrated less viru-
lence in a mouse lethality study, where the LD50 ranged from approximately 10
6 colony-forming
units (CFU) to >107 CFU. Immunological responses were not significantly correlated with KPC
subtype; however, responses were associated with MLST and capsular serotype.
Conclusion: Production of KPC itself was not associated with increased virulence despite
different variants of KPC. The ST11 KPC-producing strain was resistant to serum killing,
whereas capsular ss K1 was associated with resistance to neutrophil phagocytosis.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Klebsiella pneumoniae, particularly the hypervirulent
strains found predominantly in the Asia Pacific region, is an
important clinical pathogen that is highly associated with
mortality and morbidity.1e3 In recent years, the emergence
of carbapenem-resistant Enterobacteriaceae, including
carbapenem nonsusceptible K. pneumoniae, has made
treating infected patients particularly challenging.4,5 Since
the first report of carbapenem-resistant K. pneumoniae
(CRKP) in 1996, many studies have been conducted to
evaluate the clinical impact of CRKP. The CRKP infection-
related mortality rate is higher than those of extended-
spectrum beta-lactamase (ESBL)-producing strains and
wild-type susceptible K. pneumoniae.6,7 Moreover, infec-
tion with carbapenem-resistant strains seems to be one of
the risk factors for infection-related mortality.8,9 The
mechanisms underlying carbapenem resistance in CRKP
bacteria include the production of carbapenem-hydrolyzing
enzymes [such as Klebsiella pneumoniae carbapenemase
(KPC), Verona integron-encoded metallo-b-lactamase, New
Delhi metallo-b-lactamase, active on imipenem (IMP)-type
carbapenemases, and oxacillin-hydrolyzing (OXA)-group b-
lactamase] and the production of ESBL coupled with outer
membrane porin loss.10 Compared with other mechanisms
of resistance, infections caused by KPC-producing strains
result in increased mortality.10 To date, 16 variants of KPC
enzymes (KPC-2 to KPC-17) have been identified.11 Each
variant exhibits different characteristics, including hydro-
lytic ability and susceptibility to antimicrobials.12 Further
studies have been conducted to analyze the virulence of
KPC-producing K. pneumoniae. Most of those studies have
been performed in vitro and have revealed that the blaKPC-2
itself is not associated with the virulence of KPC-producing
K. pneumoniae.13e15 Thus, the increased mortality of
infected patients might be due to the lack of effective
treatment or might be caused by other comorbidities.
However, virulence has been analyzed only in the blaKPC-2
and blaKPC-3 variants
13e15; the association of virulence with
other subtypes of KPC genes has not been evaluated. In this
study, we evaluated and compared the virulence of
different variants of KPC isolates from Taiwan and the
United States (US) and determined the association of viru-
lence with different subtypes of KPC genes.Methods
Bacterial strains and labeling with fluorescein
isothiocyanate
Three clinical KPC strain variants, KPC2-TW, KPC3-TW, and
KPC17-TW, were isolated from Taiwan. In addition, two
clinical strains, KPC2-US and KPC3-US, isolated from the US
were also included for the purpose of comparison of
geographic variance. The main characteristics of each
strain are shown in Table 1.
The isolated K. pneumoniae were labeled with fluores-
cein isothiocyanate (FITC), as previously described, for
subsequent phagocytosis studies.16 The strains were iso-
lated and incubated overnight at 37C. The concentration
was estimated using photospectrometry (Olympus, Tokyo,
Japan) and confirmed by quantitative plate counting. The
bacteria were heat-killed for 1 hour in a 70C-water bath.
Then, the bacteria were washed with phosphate-buffered
saline (PBS) and labeled with FITC by incubation with
0.1 mg/mL FITC (Sigma Chemical Co., St. Louis, MO, US) in
0.10M NaHCO3, pH 9.0, for 60 minutes at 25C. The labeled
bacteria were washed with PBS and centrifuged to remove
unbound fluorochrome. The labeled bacteria were resus-
pended in PBS at a concentration of 2  108 cells/mL and
stored at 70C.
Serotyping and virulence gene detection by
polymerase chain reaction
Serotyping [K1, K2, K5, and multilocus sequence typing
(MLST)] was performed by polymerase chain reaction (PCR).
Ten common virulent trait genes, including allS, rmpA,
mrkD, kfuBC, cf29a, fimH, uge, wabG, and ureA17,18
(primers data listed in Table 2), which are known to be
associated with the virulence of K. pneumoniae, were also
assayed.
Serum resistance assay
An overnight culture was diluted 1:100 and grown to the
midexponential phase. An inoculum of 1  106 colony-
forming units (CFUs) was mixed with nonimmune human
Table 1 Main characteristics of the strains used in this study.
Strains Source Capsular
typing
MLST
typing
Virulence traits Reference
allS rmpA mrkD kfuBC cf29a fimH uge wabG ureA
KPC2 -TW Clinical
(TSGH, Taiwan)
Non-K1,
K2, K5
ST11 þ  þ   þ þ þ þ This study
KPC3 -TW Clinical
(VGH, Taipei,
Taiwan)
K1 ST258 þ  þ   þ þ þ þ This study
KPC17-TW Clinical
(NTUH, Taiwan)
Non-K1,
K2, K5
ST11 e  þ   þ þ þ þ This study
KPC2 -US Clinical
(New Jersey, USA)
Non-K1,
K2, K5
ST258 þ  þ   þ þ þ þ 25
KPC3 -US Clinical
(New Jersey, USA)
Non-K1,
K2, K5
ST258 þ  þ   þ þ þ þ 25
KPCZ Klebsiella pneumoniae carbapenemase; MLST Z multilocus sequence typing; NTUH Z National Taiwan University Hospital;
TSGH Z Tri-Service General Hospital; VGH Z Veterans General Hospital; e Z negative result; þ Z positive result.
Variant of KPC from Taiwan and USA 85serum, donated by healthy volunteers, in a 1:3 volume
ratio. The final mixture volume was 1 mL and was incubated
at 37oC. Serial dilutions were plated on MuellereHinton
agar for 0 hours, 0.5 hours, 1 hour, 2 hours, and 3 hours toTable 2 Primers used in this study.
Category Genes Primers Primer sequence
Capsular serotyping K1 MagAF1 5ʹ- GGTGCTCTTTACAT
MagAR1* 5ʹ- GCAATGGCCATTTG
K2 Wzy-F1 5ʹ- GACCCGATATTCAT
Wzy-R1 5ʹ- CCTGAAGTAAAATC
K5 K5wzxF360 5ʹ- TGGTAGTGATGCT
K5wzxR639 5ʹ- CCTGAACCCACCCC
The activator of
the allantoin
regulon gene
allS 1416R 5ʹ- CCGTTAGGCAATCC
336F2 5ʹ- TCTGATTTA(A/T)C
Capsular
polysaccharide
biosynthesis
gene
rmpA rmpA-F 5ʹ- ACTGGGCTACCTCT
rmpA-R 5ʹ- CTTGCATGAGCCAT
Iron uptake
system gene
kfuBC kfuB-F1179 5ʹ- GAAGTGACGCTGT
kfuC-R649 5ʹ- TTTCGTGTGGCCA
Adhesion
associated
genes
cf29a cf29a-F 5ʹ- GACTCTGATTGCAC
cf29a-R 5ʹ- GTTATAAGTTACTG
fimH fim-1 5ʹ- GCTCTGGCCGATAC
fim-2 5ʹ- GC(G/A) (A/T)A(G
GCCTGGAACGG -3ʹ
mrkD mrkD-1 5ʹ- TAT(T/C)G(G/T)CT
mrkD-2 5ʹ- TAATCGTACGTCAG
Uridine diphosphate
galacturonate
4-epimerase gene
uge uge-F 5ʹ- GATCATCCGGTCTC
uge-R 5ʹ- TCTTCACGCCTTCC
Core LPS
biosynthesis gene
wabG wabG-F 5ʹ- CGGACTGGCAGAT
wabG-R 5ʹ- ACCATCGGCCATTT
Urease synthesis
associated gene
ureA ureA-F 5ʹ- GCTGACTTAAGAG
ureA-R 5ʹ- GATCATGGCGCTAC
* This primer was designed by Fang et al.27
LPS Z lipopolysaccharide.obtain colony counts. The average percent survival was
plotted against time to obtain a survival curve in response
to serum treatment for each strain.19 The response to
serum killing was scored on a six-grade scale, as previouslySize (bp) Annealing
temperature
(C)
Reference
CATTGC -3ʹ 1283 50 26,27
CGTTAG -3ʹ
ACTTGACAGAG -3ʹ 641 50 26
GTAAATAGATGGC -3ʹ
CGCGA -3ʹ 280 50 26
AATC -3ʹ
AGAC -3ʹ 1090 48.9 28
CCACATT -3ʹ
GCTTCA -3ʹ 535 58.0 17
CTTTCA -3ʹ
TTCTGGC -3ʹ 797 55.5 29
GTGACTC -3ʹ
TGGCTGTG -3ʹ 826 51.4 17
CCACGTTC -3ʹ
(C/T)AC(C/G)ACGG -3ʹ 423 54.8 17
/A)TAACG(T/C)
TAATGGCGCTGG -3ʹ 920 50.1 17
GTTAAAGA(C/T)C -3ʹ
CCTGTA -3ʹ 534 52.7 30
TTCACT -3ʹ
CCATATC -3ʹ 683 53.8 17
GATAGA -3ʹ
AACGTTATG -3ʹ 337 55.8 17
CT(C/T)A -3ʹ
86 T.-T. Chiang et al.described.19. Grades 1 and 2 indicate high sensitivity to
serum killing, Grades 3 and 4 indicate intermediate sensi-
tivity, and Grades 5 and 6 indicate serum resistance.
Human neutrophil phagocytosis assay
Neutrophils were isolated from three healthy volunteers, as
previously described. Freshly drawn, heparinized blood was
mixed with an equal volume of dextranesaline solution.
After incubation at room temperature, the upper leukocyte-
rich plasma was aspirated. The leukocyte-rich plasma was
mixed with FicolleHypaque in a 2:1 volume ratio, layered on
a FicolleHypaque density gradient, and centrifuged. The
neutrophil/red blood cell (RBC) pellet was resuspended in
cold 0.2% NaCl. Then, ice-cold 1.6% NaCl was added, samples
were centrifuged, and the supernatant was discarded. The
above two steps were repeated one or two times or until the
cell pellets appeared free of RBC. The cell concentrationwas
adjusted to 1  107 neutrophils/mL.
The phagocytosis assay was performed as previously
described.16,20 One hundred microliters of neutrophil sus-
pension (approximately 1  106 neutrophils), 100 mL of
freshly thawed ice-cold normal human serum, and 600 mL of
PBS were added into polypropylene tubes. The tubes were
prewarmed and incubated at 37C with continuous agita-
tion. Then, 200 mL stoked, FITC-labeled bacteria (approxi-
mately 4  107 CFU/mL) was added to each tube to a final
volume of approximately 1 mL per tube. The tubes were
incubated at 37C with continuous agitation. At 0 minutes,
1 minute, 2 minutes, 4 minutes, 6 minutes, 8 minutes, 10
minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes,
45 minutes, and 60 minutes, tubes were placed immedi-
ately in an ice bath. Cells were then separated by centri-
fugation and resuspended in 1 mL of ice-cold (4C) PBS. The
suspension was placed in a new tube and mixed with
ethidium bromide (EB) such that a final EB concentration of
50 mg/mL was obtained. An unintubated tube was reserved
as a 0-minute control group.
A FACScan emitting an argon laser beam at 488 nm (Bec-
ton Dickinson Immunocytometry Systems, San Jose, CA, US)
was used to detect FITC fluorescence to measure phagocy-
tosis of K. pneumoniae by human neutrophils.16,20 The in-
strument settings were as follows: the sideways scatter (SSC)
threshold was 52. The detector was set at E00, 350, and 427
for forward scatter (FSC), SSC, and fluorescence 1 (FL 1-H,
green), respectively. Fluorescence values were obtained
after gating on the combination of all light scatters. Data
were collected from a total of 10,000 cells and analyzedwith
the Cellquest version 1.0 software (Becton Dickinson
Immunocytometry Systems). The distribution data collected
by logarithmic amplifier were displayed as single histograms
for FL1-H. After addition of EB, extracellular fluorescence
was inhibited, and cells appeared red under microscopic
examination. By contrast, FITC-stained bacteria being
engulfed by neutrophils appeared green. The ingested per-
centage of bacteria was calculated.
Mice lethality study
To determine the LD50 in a murine model, 6- to 8-week-old,
male, pathogen-free BALB/c mice (body weight 20e25 g)were obtained from the National Laboratory Animal Center.
This study was conducted under the recommendations of
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. All animal care procedures
and protocols were approved by the Institutional Animal
Care and Use Committee of the National Health Research
Institute (IACUC-14-195). Tenfold serial dilutions of bacte-
ria were prepared from a starting concentration of 107 CFU,
and the adult BALB/c mice received intraperitoneal in-
jections with three to four concentrations of each strain.
Six mice were used as a sample population for each KPC
variant strain. Inoculated mice were observed for 14 days
for symptoms of infection. Survival of the inoculated mice
was recorded daily.
Statistical analysis
The human neutrophil phagocytosis data have been
expressed as mean  standard deviation (SD). One-way
analysis of variance (ANOVA) was performed to compare the
differences in phagocytic rates from 0 minutes to 30 mi-
nutes between strains and groups. Student t test was used
to assess the differences in phagocytosis at 30 minutes
between groups. A p value  0.050 was considered stati-
cally significant.
Results
Detection of MLST, capsular type, and virulent
genes
MLST analysis demonstrated that KPC2-TW and KPC17-TW
belong to multilocus sequence type (ST) 11. KPC2-US, KPC3-
US, and KPC3-TW were categorized as ST258. Screening for
capsular typing revealed that KPC3-TW expresses serotype
K1, whereas the others were all non-K1/K2/K5 isolates.
Analysis of virulent gene factors is provided in Table 1. All
strains expressed the following virulent trait genes: mrkD,
fimH, uge, wabG, and ureA. In addition, with the exception
of the KPC17-TW strain, all strains also expressed allS. All
five strains were negative for the kfuBC, cf29a, and rmpA
genes.
Serum killing assays
KPC17-TW and KPC2-TW, both ST11 strains, demonstrated
serum resistance when incubated with normal human
serum (952.19% and 445.31% viability, respectively;
Figure 1). By contrast, the ST258 strains, KPC-2 US, KPC-3
TW, and KPC-3 US, were highly sensitive to serum killing
(0%, 0%, and 0% viability, respectively; Figure 1). When KPC-
producing isolates were subgrouped into ST11 and ST258
strains, the ST11 group was found to be more serum resis-
tant than the ST258 group (Figure 1).
Phagocytosis reaction
Neutrophils from three healthy volunteers were isolated
and incubated with each variant strain. The phagocytosis
rates of these five strains were highly variable, where the
Figure 1. Serum responses of different variants of Klebsiella pneumoniae carbapenemase(KPC)-producing K. pneumoniae iso-
lates. The response to serum killing was scored on a six-grade scale. Grades 1 and 2 indicate high sensitivity to serum killing, Grades
3 and 4 indicate intermediate sensitivity, and Grades 5 and 6 indicate serum resistance.19 KPC17-TW and KPC2-TW exhibited a
Grade 6 and a Grade 5 response, respectively, whereas KPC2-US, KPC3-TW, and KPC3-US exhibited Grade 2 responses.
KPCZ Klebsiellapneumoniae carbapenemase; TW Z Taiwan; USZ United States.
Variant of KPC from Taiwan and USA 87mean 15-minute phagocytic rates ( SD) for KPC2-TW,
KPC2-US, KPC3-TW, KPC3-US, and KPC17-TW were
60.46  19.18%, 43.44  8.02%, 27.41  10.24%,
33.81  8.84%, and 80.11  6.22%, respectively (Figure 2).
Overall, capsular serotype non-K1/K2/K5 KPC2-TW and
KPC17-TW, both ST11 strains, were relatively more sus-
ceptible to phagocytosis (60.46  19.18% and
80.11  6.22%, respectively) than the other three strains
(KPC2-US, KPC3-TW, and KPC3-US; 43.44  8.02%,
27.41  10.24%, and 33.81  8.84%, respectively). When we
further divided all variants into ST11 and ST258 strains
according to the MLST analysis, the ST11 group exhibited a
significantly higher 15-minute phagocytic rate than theFigure 2. Neutrophil phagocytic rates of different variants
of Klebsiella pneumoniae carbapenemase(KPC)-producing
K. pneumoniae isolates. Data are presented as mean phago-
cytic rate  standard deviation (SD) at 0 minutes, 5 minutes, 15
minutes, and 30 minutes. The phagocytic rates of these five
strains were highly variable with mean 15-minute phagocytic
rates ( standard deviation) for KPC2-TW, KPC2-US, KPC3-TW,
KPC3-US, and KPC17-TW being 60.46  19.18%, 43.44  8.02%,
27.41  10.24%, 33.81  8.84%, and 80.11  6.22%, respec-
tively. KPCZ Klebsiella pneumoniae carbapenemase;
SD Z standard deviation; TW Z Taiwan; USZ United States.ST258 group (70.28  16.68% vs. 34.88  10.52%, p < 0.001;
Figure 3A). There were no significant differences in the 15-
minute phagocytic rates between strains within the same
sequence typing group (ST11: pZ 0.167; ST258: pZ 0.175;
Figures 3B and 3C). There were also no significant differ-
ences in the 15-minute phagocytic rates between isolates
from Taiwan and the US (55.99  25.68% vs. 38.62  9.23%,
p Z 0.140; Figure 3D). Subgrouping strains into KPC sub-
types (KPC2, KPC3, and KPC17) revealed differences in the
phagocytic rate (p Z 0.038). However, there was no sig-
nificant difference between any two of those strains,
except KPC17 versus KPC3 (KPC2 vs. KPC3, pZ 0.166; KPC2
vs. KPC17, p Z 0.110; KPC17 vs. KPC3, p Z 0.022;
Figure 3E). In addition, the capsular serotype K1 KPC3-TW
strain was relatively resistant to phagocytosis compared
with the other non-K1/K2/K5 isolates (15-minute phago-
cytic rate, 27.1  10.23% vs. 54.46  20.94%, p Z 0.050;
Figure 3F).
Mouse lethality study
All five isolates demonstrated relatively less virulence in
the murine model, wherein the LD50 of all isolates ranged
from 1.0091  106 CFU to >107 CFU.
Discussion
The emergence of CRKP, including KPC-producing K. pneu-
moniae, has proven to be a great challenge for physicians
not only because of its multidrug resistance but also
because of the higher mortality and morbidity rates of
infected patients.4,8,9 Previous studies evaluating the
virulence and characteristics of KPC-producing K. pneu-
moniae concluded that expressing the blaKPC-2 gene itself is
not associated with increased virulence.13e15 In addition,
different variants of KPC enzymes that exhibited different
characteristics were also discovered.12 Our study
Figure 3. Phagocytic rates of five Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae isolates. Data are
presented as mean phagocytic rate  SD at 0 minutes, 5 minutes, 15 minutes, and 30 minutes. (A) Comparison of neutrophil
phagocytic rates of different MLST strains. ST11 strains include KPC2-TW and KPC17-TW; ST258 strains include KPC2-US, KPC3-US,
and KPC3-TW. The ST11 strains exhibited a significantly higher 15-minute phagocytic rate than ST258 strains (p < 0.001).
(B) Comparison of neutrophil phagocytic rates for all ST11 strains (KPC2-TW and KPC17-TW). There was no statistically significant
difference in 15-minute (pZ 0.167) or 30-minute phagocytic rates (pZ 0.365). (C) Comparison of neutrophil phagocytic rates for
all ST258 strains (KPC2-US, KPC3-US, and KPC3-TW). There was no statistically significant difference in 15-minute (pZ 0.175) or 30-
minute phagocytic rates (p Z 0.770). (D) Comparison of neutrophil phagocytic rates for strains from Taiwan and the US. TW
represents isolates from Taiwan. There were no statistically significant differences in the 15-minute phagocytic rates (pZ 0.140).
(E) Comparison of neutrophil phagocytic rates between strains expressing different variants of KPCs. Overall, the neutrophil
phagocytic rates differed between these three groups (p Z 0.038). However, there were no significant differences between any
two of those strains, with the exception of KPC17 versus KPC3 (KPC2 vs. KPC3, p Z 0.166; KPC2 vs. KPC17, p Z 0.110; KPC17 vs.
KPC3, pZ 0.022). (F) Comparison of neutrophil phagocytic rates between strains with different capsular typing. The capsular type
K1 strain was more resistant to neutrophil phagocytosis than non-K1/K2/K5 strains (15-minute phagocytic rate: 27.1  10.23% vs.
54.46  20.94%, p Z 0.050). KPCZ Klebsiella pneumoniae carbapenemase; MLST Z multilocus sequence typing; SD Z standard
deviation; TW Z Taiwan; USZ United States.
88 T.-T. Chiang et al.demonstrated that all five KPC-producing K. pneumoniae
isolates, expressing different variants of KPC enzymes,
were less virulent, with the LD50 exceeding 10
6 CFU. We
found that the blaKPC-2 expressing strains and the other
variants we tested were not associated with the increased
virulence of K. pneumoniae.
Although these strains were not particularly virulent,
we still identified different immunological characteristics
among different subtypes. There were no significant cor-
relations between KPC variant subtypes and the response
to serum killing. KPC3-TW and KPC3-US were both highly
sensitive to serum killing; however, KPC2-TW and KPC2-USdiffered greatly, with the former being serum resistant
and the latter being highly serum sensitive. There was also
no significant association between the variant subtypes
and the neutrophil phagocytic rate. By contrast, different
MLST isolates may be associated with different serum re-
sponses and neutrophil phagocytic responses. The ST11
isolates were resistant to serum killing, whereas the ST258
isolates were highly sensitive. ST11 isolates had a signifi-
cantly higher phagocytic rate than ST258 isolates. Previous
studies have also demonstrated that different STs may be
associated with different serum complement kill
responses.21
Variant of KPC from Taiwan and USA 89Comparison between geographic regions revealed that
isolates from the US all belonged to ST258, whereas those
from Taiwan belonged predominantly to ST11, with the
exception of KPC3-TW. Additional analysis of patient his-
tories revealed that the patient infected with the KPC3-TW
isolate had just returned from the US, where he had been
hospitalized. The clinical isolate was collected at Veteran
General Hospital in Taipei just a few days after the patient
had returned to Taiwan. Based on these findings, we pro-
pose that the patient was likely infected with KPC3-TW in
the US and only discovered this after returning to Taiwan.
Thus, excluding this isolate, in this study, all clinical iso-
lates from Taiwan belonged to the ST11 clonal complex,
whereas the isolates from the US belonged to the ST258
complex. The geographic difference in predominant sero-
type was also consistent with the findings of previous
studies.22e24
The capsular serotype K1 KPC3-TW was relatively more
resistant to neutrophil phagocytosis than the other non-K1/
K2/K5 serotype isolates (15-minute phagocytic rate,
27.1  10.23% vs. 54.46  20.94%, pZ 0.050). The capsular
serotype may not affect the serum response. Both the
capsular serotype K1 KPC3-TW and the non-K1/K2/K2
serotype KPC3-US, which belong to the same ST258 group
and express the KPC3 enzyme, were highly sensitive to
serum killing.
This study has some limitations. Only three variants and
a total of five strains of KPC-producing K. pneumoniae
clinical isolates were analyzed in this study. Thus, there are
still many variants that have not been evaluated. Further
studies to evaluate the virulence of all known variant sub-
types, with more clinical isolates included, should be con-
ducted to confirm the current results. Moreover, in this
study, we only surveyed 10 common virulence traits to
exclude other confounding factors that may be associated
with the virulence of these strains. There are still many
known and even unknown virulent factors that were not
evaluated in our study.
In conclusion, we propose that neither the blaKPC-2 gene
itself nor the genes encoding the other variant subtypes of
KPC enzymes are associated with increased virulence. The
higher mortality and morbidity rates of KPC-producing K.
pneumoniae infected patients may be associated with
other factors, such as lack of effective therapy, multiple
comorbidities of the infected patients etc. In addition,
different strain types identified by MLST may be associated
with different immune responses. Further studies investi-
gating additional clinical isolates and analyzing all variant
subtypes of KPC enzymes should be conducted to evaluate
the trend found in this study.Conflicts of interest
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